On 9/6/22 the FDA approved Stanford’s SAINT Neuromodulation, an accelerated version of TMS that has raised hopes with unusually high remission rates.

CME: Podcast CME Post-Tests are available using this subscription. If you have already enrolled in that program, please log in.

Published On: 09/12/22

Duration: 14 minutes, 00 seconds